Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Transfusion
|
September 2, 2022
Why the majority of on-site repeat donor deferrals are completely unwarranted…
Mart P Janssen
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 13, 2009
Enhancing value of information analyses
Mart P Janssen, Hendrik Koffijberg
Transfusion
|
April 10, 2015
Health economics and outcomes methods in risk-based decision-making for blood safety
Brian Custer, Mart P Janssen,
Transfusion
|
May 25, 2016
A consensus-based tool for ranking the risk of blood-transmissible infections
Welling Oei, Rabin Neslo, Mart P Janssen
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 26, 2018
The Impact of Decision Makers' Constraints on the Outcome of Value of Information Analysis
Hendrik Koffijberg, Saskia Knies, Mart P Janssen
Vox Sanguinis
|
September 14, 2022
Explainable haemoglobin deferral predictions using machine learning models: Interpretation and consequences for the blood supply
Marieke Vinkenoog, Matthijs van Leeuwen, Mart P Janssen
Transfusion Medicine Reviews
|
July 27, 2013
Viral safety of human plasma-derived medicinal products: impact of regulation requirements
Karin J Velthove, Jan Over, Kristiena Abbink, et al.
Vox Sanguinis
|
April 26, 2021
West Nile virus and blood transfusion safety: A European perspective
Rossana C Garzon Jimenez, Ryanne W Lieshout-Krikke, Mart P Janssen
Transfusion
|
June 10, 2010
Demographic changes and predicting blood supply and demand in the Netherlands
Barbara A Borkent-Raven, Mart P Janssen, Cees L Van Der Poel
Health Informatics Journal
|
June 2, 2021
Evaluating privacy of individuals in medical data
Shannon Ks Kroes, Mart P Janssen, Rolf Hh Groenwold, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Transfusion
|
September 2, 2022
Why the majority of on-site repeat donor deferrals are completely unwarranted…
Mart P Janssen
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 13, 2009
Enhancing value of information analyses
Mart P Janssen, Hendrik Koffijberg
Transfusion
|
April 10, 2015
Health economics and outcomes methods in risk-based decision-making for blood safety
Brian Custer, Mart P Janssen,
Transfusion
|
May 25, 2016
A consensus-based tool for ranking the risk of blood-transmissible infections
Welling Oei, Rabin Neslo, Mart P Janssen
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 26, 2018
The Impact of Decision Makers' Constraints on the Outcome of Value of Information Analysis
Hendrik Koffijberg, Saskia Knies, Mart P Janssen
Vox Sanguinis
|
September 14, 2022
Explainable haemoglobin deferral predictions using machine learning models: Interpretation and consequences for the blood supply
Marieke Vinkenoog, Matthijs van Leeuwen, Mart P Janssen
Transfusion Medicine Reviews
|
July 27, 2013
Viral safety of human plasma-derived medicinal products: impact of regulation requirements
Karin J Velthove, Jan Over, Kristiena Abbink, et al.
Vox Sanguinis
|
April 26, 2021
West Nile virus and blood transfusion safety: A European perspective
Rossana C Garzon Jimenez, Ryanne W Lieshout-Krikke, Mart P Janssen
Transfusion
|
June 10, 2010
Demographic changes and predicting blood supply and demand in the Netherlands
Barbara A Borkent-Raven, Mart P Janssen, Cees L Van Der Poel
Health Informatics Journal
|
June 2, 2021
Evaluating privacy of individuals in medical data
Shannon Ks Kroes, Mart P Janssen, Rolf Hh Groenwold, et al.
Page
of 6